Streetbeat News

Analyst Ratings

TSN

Piper Sandler has downgraded Tyson Foods from Neutral to Underweight and reduced its price target from $57 to $50.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2024 | 2:58 pm

USFD

Jefferies analyst Alexander Slagle maintains a Buy rating on US Foods Holding (NYSE:USFD) and raises the price target from $66 to $71.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2024 | 2:53 pm

SYY

Jefferies analyst Adam Samuelson maintains a Buy rating on Sysco (NYSE:SYY) and raises the price target from $91 to $92.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2024 | 2:51 pm

PRGS

DA Davidson analyst Lucky Schreiner maintains a Buy rating on Progress Software (NASDAQ:PRGS) and raises the price target from $65 to $70.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2024 | 2:46 pm

MNDY

DA Davidson analyst Gil Luria maintains a Neutral rating on Monday.Com (NASDAQ:MNDY) but raises the price target from $250 to $300.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2024 | 2:44 pm

SFIX

Canaccord Genuity analyst Maria Ripps maintains a Hold rating on Stitch Fix (NASDAQ:SFIX) and lowers the price target from $4.5 to $3.5.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2024 | 2:39 pm

APP

Macquarie analyst Tim Nollen has reiterated an Outperform rating on AppLovin and increased the price target from $115 to $150.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2024 | 2:38 pm

PODD

Canaccord Genuity has maintained its Buy rating on Insulet (NASDAQ:PODD) and raised the price target from $236 to $269, indicating a positive outlook for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2024 | 2:36 pm

AMGN

Amgen's shares are declining due to atopic dermatitis data that failed to meet analysts' expectations, highlighting competitive pressures in the market.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2024 | 2:34 pm

IRTC

Canaccord Genuity has maintained a Buy rating on iRhythm Technologies and increased the price target from $122 to $137, indicating a positive outlook for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2024 | 2:33 pm